Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander G Robling

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Journal of Neurosurgery|November 11, 2017
Loss of mechanosensitive sclerostin may accelerate cranial bone growth and regenerationKyung Shin Kang, Jeff Lastfogel, Laurie L Ackerman, et al.
Journal of Cellular Physiology|February 4, 2009
Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular boneAlexander G Robling, Paul Childress, Jun Yu, et al.
Bone|August 23, 2011
High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypesPaul J Niziolek, Takeisha L Farmer, Yajun Cui, et al.
Journal of Cellular Physiology|September 6, 2007
HMGB1 is a bone-active cytokineJieping Yang, Rita Shah, Alexander G Robling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 9, 2023
Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in MiceRoy B Choi, April M Hoggatt, Daniel J Horan, et al.
Plos One|April 5, 2019
Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growthNoah J Mathis, Emily N Adaniya, Lauren M Smith, et al.
Aging and Disease|December 5, 2022
Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged SkeletonRoy B Choi, April M Hoggatt, Daniel J Horan, et al.
Bone|November 9, 2020
Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administrationKyung-Eun Lim, Whitney A Bullock, Daniel J Horan, et al.
JBMR Plus|May 12, 2021
Improving Bone Health by Optimizing the Anabolic Action of Wnt Inhibitor MultitargetingRoy B Choi, Whitney A Bullock, April M Hoggatt, et al.
Journal of Biomechanics|January 18, 2005
A comparison of mechanical properties derived from multiple skeletal sites in miceJennifer L Schriefer, Alexander G Robling, Stuart J Warden, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Journal of Neurosurgery|November 11, 2017
Loss of mechanosensitive sclerostin may accelerate cranial bone growth and regenerationKyung Shin Kang, Jeff Lastfogel, Laurie L Ackerman, et al.
Journal of Cellular Physiology|February 4, 2009
Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular boneAlexander G Robling, Paul Childress, Jun Yu, et al.
Bone|August 23, 2011
High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypesPaul J Niziolek, Takeisha L Farmer, Yajun Cui, et al.
Journal of Cellular Physiology|September 6, 2007
HMGB1 is a bone-active cytokineJieping Yang, Rita Shah, Alexander G Robling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 9, 2023
Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in MiceRoy B Choi, April M Hoggatt, Daniel J Horan, et al.
Plos One|April 5, 2019
Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growthNoah J Mathis, Emily N Adaniya, Lauren M Smith, et al.
Aging and Disease|December 5, 2022
Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged SkeletonRoy B Choi, April M Hoggatt, Daniel J Horan, et al.
Bone|November 9, 2020
Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administrationKyung-Eun Lim, Whitney A Bullock, Daniel J Horan, et al.
JBMR Plus|May 12, 2021
Improving Bone Health by Optimizing the Anabolic Action of Wnt Inhibitor MultitargetingRoy B Choi, Whitney A Bullock, April M Hoggatt, et al.
Journal of Biomechanics|January 18, 2005
A comparison of mechanical properties derived from multiple skeletal sites in miceJennifer L Schriefer, Alexander G Robling, Stuart J Warden, et al.
Pageof 14